Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Naltrexone shows promise for treatment of amphetamine dependence
July 25th, 2005
In an early clinical study, treatment with the opioid antagonist naltrexone significantly reduced amphetamine use in addicted patients. In the Nordic Journal of Psychiatry, investigators in Sweden presented the results of an "open-label clinical trial" conducted "to assess the feasibility of naltrexone as a potential pharmacotherapy for amphetamine dependence." A total of "20 amphetamine-dependent patients" were enrolled, according to N. Jayaram-Lindström and coauthors at Karolinska University Hospital. Study participants received "12 weeks of treatment comprised of naltrexone (50 mg) along with relapse prevention therapy," and "were assessed...
Source: Health & Medicine Week (2005-07-25)
|
